Kazakhstan vs Myanmar: Treatment success rate: XDR-TB cases
Kazakhstan
75
in 2022
Myanmar
79
in 2022
Kazakhstan rank
29th
Myanmar rank
27th
Treatment success rate: XDR-TB cases over time
- Kazakhstan
- Myanmar
How they compare
Myanmar currently reports 79 against 75 in Kazakhstan, a difference of 4.
That makes Myanmar's figure about 1.1 times Kazakhstan's.
The two have swapped places 2 times across 8 shared years of data; in 2015 it was Myanmar ahead.
Kazakhstan ranks 29th and Myanmar ranks 27th of 82 countries.
Myanmar has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Kazakhstan | Myanmar | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 55.4 | 65.8 | 10.4 | Myanmar |
| 2020s | 76.67 | 88 | 11.33 | Myanmar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate: xdr-tb cases, Kazakhstan or Myanmar?
- Myanmar, at 79 against 75 in Kazakhstan as of 2022.
- What is the difference in treatment success rate: xdr-tb cases between Kazakhstan and Myanmar?
- 4, with Myanmar ahead.
- How many years of comparable data are there for Kazakhstan and Myanmar?
- 8 years are reported by both, from 2015 to 2022.
- How do Kazakhstan and Myanmar rank globally for treatment success rate: xdr-tb cases?
- Kazakhstan ranks 29th and Myanmar ranks 27th of 82 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate: XDR-TB cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.